Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03588091 |
|---|---|
| Brief Title: | Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer |
| First Submitted : | June 18, 2018 |
| First Submitted that Met QC Criteria : | July 3, 2018 |
| First Posted : | July 17, 2018 |
| Last Update Submitted that Met QC Criteria : | August 3, 2021 |
| Last Update Posted : | August 4, 2021 |